Ignite Creation Date:
2024-05-05 @ 11:25 PM
Last Modification Date:
2024-10-26 @ 10:33 AM
Study NCT ID:
NCT01327547
Status:
COMPLETED
Last Update Posted:
2017-12-06
First Post:
2011-03-22
Brief Title:
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C AndOr Hepatitis B
Sponsor:
ViiV Healthcare
Organization:
ViiV Healthcare
Study Overview
Official Title:
A Multicenter Randomized Blinded Placebo-controlled Study To Evaluate The Safety Of Maraviroc In Combination With Other Antiretroviral Agents In Hiv-1-infected Subjects Co-infected With Hepatitis C Andor Hepatitis B Virus
Status:
COMPLETED
Status Verified Date:
2017-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To describe liver enzyme elevations in patients who are coinfected with HIV and either Hepatitis C HCV andor Hepatitis B HBV receiving maraviroc or placebo in combination with their current suppressive anti-HIV drug therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2010-021994-35 | EUDRACT_NUMBER | None | None |